28BIO (AXOSIM)
Company Snapshot
Founded: 2014
Entity Type: Private
Region: U.S.
Headquarter: Los Angeles, U.S.
Key Geographics: U.S.
Corporate Address: 4224 Houma Boulevard, Suite 224 Metairie, Los Angeles 70006, U.S. Tel: +1-504-609-3469 www.28bio.com
Company Overview
AxoSim, a spin-off of Tulane University in 2014, developed proprietary technology for a brain-on-a-chip in vitro model. The platform is developed by combining neural interfacing, artificial intelligence, and tissue engineering technologies. AxoSim’s biomimetic platforms help fasten the development of CNS drugs to combat diseases, including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, and other neurological disorders. AxoSim's brain-on-a-chip models exhibit over 90% accuracy in evaluating human outcomes compared to 30% in animal models.
Company's Business Segments
- Products : CNS-3D Brain Organoids, CNS-3D Inflammatory Organoids, CNS-3D Myelinated Organoids, CNS-3D Alzheimer's Model
- Services : CNS-3D Services, PNS-3D Services, Others
Applications/End User Industries
- Healthcare
- Pharmaceutical
- Biotechnology
- Life Sciences